ASHENEWS reports that the National Agency for Food and Drugs Administration and Control (NAFDAC) has issued a public alert over the circulation of two counterfeit batches of Avastin 400mg/16ml, an anticancer medication manufactured by Roche Diagnostics GmbH, Germany.
Trending
- Lagos shoppers get pepper relief, but tomatoes remain costly
- Philanthropist Ikpea donates N2.227bn, 62-bed medical centre to Ewatto community
- NDLEA arrests South African woman with 36kg of cocaine
- Africa Intelligence Report targets decision-makers with security, political risk analysis
- Lagos residents struggle without reliable water
- At 14, Burkina Faso teenager launches FasoNova, an AI built for local needs
- Nigeria’s net FX flows hit $22.5bn, highest since 2019
- FG approves ₦50,000 NECO exam fee for 2027
